About A1c

What is A1C?

A1C test results are reported as a percentage. A higher percentage indicates higher blood glucose levels in the past 2 to 3 months.
The A1C blood test is used to diagnose diabetes, plan your diabetes treatment, and monitor how well your treatment is working over time. (source)
A normal A1C level is below 5.7%, a level of 5.7% to 6.4% indicates prediabetes, and a level of 6.5% or more indicates diabetes. (source)

The higher the levels, the greater your risk of developing diabetes complications.

The ADA recommends that the goal for most adults with diabetes is an A1C level of less than 7%. However, there’s no one-size-fits-all target. The individual goal will depend on many things, such as your age and other medical conditions. Consult your doctor to set your own individual A1C goal. (source,source)

Unlike the glucose test, the A1C test does not require fasting before having blood drawn.

The OBM rapid A1c test allows a 5-minute A1C test at home using a fingerstick blood sample, offering laboratory-level accuracy.


Read our most recent insights for people with diabetes and healthcare professionals.

Health Inequity in Communities of Color: Why Education and Early Testing Are Life-Saving

Health inequity has long been an issue in the U.S. among communities of color. The effects of this widespread and persistent issue are devastating, resulting in higher prevalence and death

ADA 2023 Recap – New Method of A1c Testing for Better Diabetes Management and Diagnosis and More

The 83rd ADA 2023 Scientific Sessions occurred from June 23 – 26th in San Diego, California this year. Many industry leaders and innovators attended this year’s conference to address the

The AADA Is Leading the Fight Against Diabetes and Health Inequity

Health problems in the U.S. disproportionately impact Black Americans due to gaps in health care, socioeconomic inequalities, and systemic racism. As a result, organizations such as the African American Diabetes

Minority Patient Groups at Higher Risk of Developing Diabetes and Receiving Inaccurate A1c Readings

Minority Patient Groups at Higher Risk of Developing Diabetes and Receiving Inaccurate A1c Readings The United States is home to many cultural and ethnic diversity. With this comes recognition of

Orange Biomed to Present a Revolutionary New Method of A1c Testing at ADA 2024 – Preview Before Public Release

Learn How The Microfluidic Technology In OBM rapid A1c, A New At-Home Device For Monitoring HbA1C, Can Generate Lab-Accurate Results From A Single Drop of Blood For More Accessible And

Orange Biomed to Attend MEDICA & Diabetes Technology Meeting to Spread Awareness of A1c Testing Gaps

Seattle, WA, October 30, 2023—Orange Biomed—a healthcare startup with cutting-edge diabetes management technology—announced their attendance at major industry events: Diabetes Technology Meeting and MEDICA. Orange Biomed is a medical device